Literature DB >> 26590599

Elevated plasma tumor necrosis factor-α receptor 2 and resistin are associated with increased incidence of kidney function decline in Chinese adults.

Gang Liu1, Yueyi Deng2, Liang Sun1, Xingwang Ye1, Pang Yao1, Yao Hu1, Feijie Wang1, Yiwei Ma1, Huaixing Li1, Yong Liu1, Qi Sun3,4, Xu Lin5.   

Abstract

Adipokines and inflammatory markers have been linked to kidney disease in animal models; however, evidence from prospective human studies is sparse. Recruited from Beijing and Shanghai in 2005, a total number of 2220 non-institutionalized Chinese individuals aged 50-70 years with baseline estimated glomerular filtration rate (eGFR) >60 mL/min/1.73 m(2) were prospectively followed for 6 years. Plasma levels of resistin, retinol-binding protein 4 (RBP4), interleukin-6 (IL-6), C-reactive protein (CRP), and tumor necrosis factor-α receptor 2 (TNF-R2) were determined at baseline. Kidney function decrease was assessed by measurements of eGFR over 6 years. Incident-reduced eGFR was defined as the onset of eGFR <60 mL/min/1.73 m(2), according to the Modification of Diet in Renal Disease Study Equation for Chinese. During the 6 years of follow-up, 333 (15.0 %) participants had incident-reduced eGFR. Each 1 standard deviation elevated concentration of resistin [relative risk (RR) 1.10; 95 % CI 1.00-1.24] and TNFR-2 (RR 1.30; 95 % CI 1.13-1.49) at baseline were significantly associated with a higher risk of incident-reduced eGFR. Comparing the highest with the lowest quartiles, the RR of incident-reduced eGFR was 1.43 (95 % CI 1.01-2.03) for resistin and 2.03 (95 % CI 1.41-2.93) for TNF-R2 (both P trend < 0.05) after adjustment for baseline demographic characteristics, lifestyle behaviors, BMI, plasma lipid profile, hypertension, and diabetes. These associations remained significant when further controlling for levels of RBP4, IL-6, and CRP, none of which was significantly associated with the risk of incident-reduced eGFR. In this prospective cohort study, elevated levels of resistin and TNF-R2, but not other adipokines and inflammatory markers, were independently associated with a greater risk of kidney function decline in middle-aged and elderly Chinese.

Entities:  

Keywords:  Adipokines; Inflammatory markers; Kidney function decline; Prospective study

Mesh:

Substances:

Year:  2015        PMID: 26590599     DOI: 10.1007/s12020-015-0807-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  49 in total

1.  Prevention of chronic kidney disease: a global challenge.

Authors:  Aminu K Bello; Emeka Nwankwo; A Meguid El Nahas
Journal:  Kidney Int Suppl       Date:  2005-09       Impact factor: 10.545

2.  Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese.

Authors:  Geng Zong; Jingwen Zhu; Liang Sun; Xingwang Ye; Ling Lu; Qianlu Jin; He Zheng; Zhijie Yu; Zhenni Zhu; Huaixing Li; Qi Sun; Xu Lin
Journal:  Am J Clin Nutr       Date:  2013-06-26       Impact factor: 7.045

3.  Tumor necrosis factor induces glomerular damage in the rabbit.

Authors:  T Bertani; M Abbate; C Zoja; D Corna; N Perico; P Ghezzi; G Remuzzi
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

4.  Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

Authors:  Monika A Niewczas; Tomohito Gohda; Jan Skupien; Adam M Smiles; William H Walker; Florencia Rosetti; Xavier Cullere; John H Eckfeldt; Alessandro Doria; Tanya N Mayadas; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

5.  Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people.

Authors:  Qibin Qi; Zhijie Yu; Xingwang Ye; Feng Zhao; Ping Huang; Frank B Hu; Oscar H Franco; Jing Wang; Huaixing Li; Yong Liu; Xu Lin
Journal:  J Clin Endocrinol Metab       Date:  2007-09-18       Impact factor: 5.958

6.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

Authors:  A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2007-06-13       Impact factor: 10.612

7.  Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lori D Bash; Thomas P Erlinger; Josef Coresh; Jane Marsh-Manzi; Aaron R Folsom; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2008-12-24       Impact factor: 8.860

8.  Associations of inflammatory factors with glycaemic status among middle-aged and older Chinese people.

Authors:  Xingwang Ye; Oscar H Franco; Zhijie Yu; Huaixing Li; Frank B Hu; Huaiyu Liu; Xiangdong Wang; Haiying Tang; Yong Liu; Yan Chen; Xu Lin
Journal:  Clin Endocrinol (Oxf)       Date:  2008-09-02       Impact factor: 3.478

9.  Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Jade S Hiramoto; Ronit Katz; Carmen A Peralta; Joachim H Ix; Linda Fried; Mary Cushman; David Siscovick; Walter Palmas; Mark Sarnak; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2012-05-04       Impact factor: 8.860

10.  Circulating adipocytokines and chronic kidney disease.

Authors:  Katherine T Mills; L Lee Hamm; A Brent Alper; Chad Miller; Alhakam Hudaihed; Saravanan Balamuthusamy; Chung-Shiuan Chen; Yanxi Liu; Joseph Tarsia; Nader Rifai; Myra Kleinpeter; Jiang He; Jing Chen
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

View more
  7 in total

1.  Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate.

Authors:  Feijie Wang; Liang Sun; Qi Sun; Liming Liang; Xianfu Gao; Rongxia Li; An Pan; Huaixing Li; Yueyi Deng; Frank B Hu; Jiarui Wu; Rong Zeng; Xu Lin
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-08       Impact factor: 8.237

2.  Use of Proteomics To Investigate Kidney Function Decline over 5 Years.

Authors:  Axel C Carlsson; Erik Ingelsson; Johan Sundström; Juan Jesus Carrero; Stefan Gustafsson; Tobias Feldreich; Markus Stenemo; Anders Larsson; Lars Lind; Johan Ärnlöv
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-21       Impact factor: 8.237

3.  Distribution of estimated glomerular filtration rate and determinants of its age dependent loss in a German population-based study.

Authors:  Thomas Waas; Andreas Schulz; Johannes Lotz; Heidi Rossmann; Norbert Pfeiffer; Manfred E Beutel; Irene Schmidtmann; Thomas Münzel; Philipp S Wild; Karl J Lackner
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

4.  High serum resistin levels are associated with peripheral artery disease in the hypertensive patients.

Authors:  Bang-Gee Hsu; Chung-Jen Lee; Chiu-Fen Yang; Yu-Chih Chen; Ji-Hung Wang
Journal:  BMC Cardiovasc Disord       Date:  2017-03-15       Impact factor: 2.298

5.  Renal expression of cytokines and chemokines in diabetic nephropathy.

Authors:  Liliane Silvano Araújo; Bianca Gonçalves Silva Torquato; Crislaine Aparecida da Silva; Maria Luíza Gonçalves Dos Reis Monteiro; Ana Luisa Monteiro Dos Santos Martins; Marcos Vinícius da Silva; Marlene Antônia Dos Reis; Juliana Reis Machado
Journal:  BMC Nephrol       Date:  2020-07-28       Impact factor: 2.388

6.  Analysis of serum inflammatory mediators in type 2 diabetic patients and their influence on renal function.

Authors:  Liliane Silvano Araújo; Marcos Vinícius da Silva; Crislaine Aparecida da Silva; Maria de Fátima Borges; Heloísa Marcelina da Cunha Palhares; Laura Penna Rocha; Rosana Rosa Miranda Corrêa; Virmondes Rodrigues Júnior; Marlene Antônia Dos Reis; Juliana Reis Machado
Journal:  PLoS One       Date:  2020-03-04       Impact factor: 3.240

Review 7.  The Signaling Pathway of TNF Receptors: Linking Animal Models of Renal Disease to Human CKD.

Authors:  Irina Lousa; Flávio Reis; Alice Santos-Silva; Luís Belo
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.